A recent study by Girona et al. [9] found that higher levels of circulating GDF15 are associated with components of cardiometabolic risk in patients with metabolic conditions, including obesity, metabolic syndrome, diabetes, or cardiovascular disease. The gene discussed is GDF15; the disease is obesity due to melanocortin 4 receptor deficiency.